0000899243-18-001093.txt : 20180116 0000899243-18-001093.hdr.sgml : 20180116 20180116184715 ACCESSION NUMBER: 0000899243-18-001093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180112 FILED AS OF DATE: 20180116 DATE AS OF CHANGE: 20180116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS CENTRAL INDEX KEY: 0001413822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37609 FILM NUMBER: 18529533 MAIL ADDRESS: STREET 1: 333 ALLERTON AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia Inc CENTRAL INDEX KEY: 0001552451 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-12 0 0001552451 MyoKardia Inc MYOK 0001413822 GIANAKAKOS ANASTASIOS C/O MYOKARDIA, INC. 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Common Stock 2018-01-12 4 M 0 5000 1.5068 A 514117 D Common Stock 2018-01-12 4 S 0 5000 50.00 D 509117 D Common Stock 181169 I By Reporting Person's Trust Stock Option (Right to Buy) 1.5068 2018-01-12 4 M 0 5000 0.00 D 2025-06-03 Common Stock 5000 146912 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. 25% of the shares subject to the option vested and became exercisable on June 4, 2016, and the remaining shares subject to this option vest and become exercisable in monthly installments through June 4, 2019. /s/ Jake Bauer, Attorney-in-Fact 2018-01-16